Metabolic psychiatry: what it is and what the research shows

How metabolism and mental health are connected

Metabolism includes the processes that make energy available and regulate its use. Researchers in this field examine insulin signaling, mitochondrial function, inflammation and the ways these processes relate to brain function. Clinical care also involves more familiar measures: weight trajectory, blood pressure, glucose regulation and blood lipids. ^{[1] [3]}

The relationship can run through several pathways. A medication may improve psychiatric symptoms while affecting weight or glucose. Sleep, activity, food access and illness itself may also influence metabolic health. Peripheral measurements such as HbA1c or triglycerides answer useful medical questions; their relationship to a particular person’s psychiatric symptoms requires clinical interpretation.

Observational research helps identify possible connections. In a 2021 Dutch cohort of 601 adults without a lifetime history of depression or anxiety disorders, several markers associated with insulin resistance predicted subsequent depression. That finding supports further investigation. It does not establish that changing a marker will prevent depression. ^[4]

Metabolic psychiatry, nutritional psychiatry and ketogenic therapy

Metabolic psychiatry encompasses research on nutrition, metabolic illness, medication effects and biologically targeted treatments. A 2026 field review discusses exercise and dietary approaches alongside research on medications such as metformin and GLP-1 receptor agonists. Ketogenic dietary therapy is a specific approach within that work. ^[5]

Related terminology can otherwise make different interventions sound interchangeable.

For example, the 2017 SMILES trial studied dietary improvement as an adjunctive treatment for depression using a Mediterranean-style approach. Its findings contribute to nutritional psychiatry, while answering a different intervention question from a ketogenic trial. ^[6]

Major metabolic psychiatry researchers

The field brings together psychiatric trials, metabolic medicine, neuroscience and nutrition research. Their contributions carry different kinds of evidence.

Major theoretical work also examines mitochondria and brain metabolism. The mechanisms remain under investigation, and clinical interpretation should follow the population, comparison and outcomes in each study.

What does metabolic psychiatry research show?

Early ketogenic studies in bipolar disorder and schizophrenia

Danan and colleagues reported a retrospective series of 31 psychiatric inpatients in 2022, with 28 included in the final analysis. Psychiatric and metabolic measures improved during adjunctive ketogenic treatment. Hospital care, changes in treatment, selection of adherent participants and unblinded assessment all limit what can be attributed to the diet. ^[12]

Sethi and colleagues enrolled 23 people with schizophrenia or bipolar disorder in a four-month single-arm pilot published in 2024. The study reported improvements in metabolic and psychiatric measures. Its lack of a control group leaves uncertainty about the contribution of ketosis, weight change, other dietary changes and the support provided. ^[15]

The Edinburgh bipolar work adds an important distinction. Participants were euthymic at entry, meaning their mood was relatively stable. Twenty completed the intervention, and standard depression and mania scales did not change significantly. The 2023 feasibility paper and 2025 outcome paper describe the same cohort. ^[16][9]

Ketogenic diet for depression: the 2026 randomized trial

A randomized trial published in 2026 assigned 88 adults with treatment-resistant depression to a ketogenic or active comparison diet, with support in both groups. At six weeks, the ketogenic group’s additional improvement was 2.18 PHQ-9 points, with a 95% confidence interval from 0.03 to 4.33 points in its favor. The result was borderline statistically significant and smaller than the five-point difference the investigators had planned to detect. The between-group difference was not statistically significant at 12 weeks. ^[17]

Both groups improved substantially. An alternative statistical model weakened the six-week finding, and ketone concentrations did not correlate with depression improvement. These details leave uncertainty about clinical importance, durability and the mechanism of any benefit.

Psychosis: controlled results and an uncontrolled extension

The 2026 psychosis study randomized 58 adults to ketogenic or usual diets for one month. It found between-group differences in metabolic measures. Later psychiatric and cognitive improvements were reported among 25 people completing a four-month ketogenic extension, compared with their own baseline. That extension provides a preliminary signal with greater uncertainty than a sustained randomized comparison. ^[10]

Systematic reviews and the populations they studied

A review published online in 2025 and in the January 2026 issue of JAMA Psychiatry found a pooled depression-symptom signal across ten randomized comparisons, with substantial variation among studies. Anxiety results across nine randomized comparisons were inconclusive. Its overall total of 50 studies included several study designs. The population size should be interpreted in that context. ^[18]

A separate 2026 review combined serious mental illness and neurocognitive disorders. The controlled evidence supporting pooled cognitive benefits largely came from the neurocognitive populations. Those findings require a separate interpretation from evidence for bipolar disorder or schizophrenia. ^[19]

How strong is the evidence for metabolic psychiatry?

These ratings reflect the study designs, consistency, directness, sample sizes and duration of the evidence discussed here. They are qualitative assessments for this article.

Metabolic health, type 2 diabetes and sleep apnea

Type 2 diabetes and obstructive sleep apnea make metabolic health particularly relevant to a treatment plan. Dietary and weight-management interventions can improve some clinical outcomes, although the contribution of ketosis differs across studies. A favorable change in one laboratory value also leaves other questions to be answered.

The ketogenic diet and mental health guide examines diabetes, sleep apnea, medication-related weight concerns, lipid changes and the monitoring questions that follow from the evidence.

Long-term outcomes require long-term trials. In Look AHEAD, an intensive lifestyle intervention improved weight and glycemic measures in adults with type 2 diabetes, while the primary cardiovascular event outcome did not significantly decline. That trial illustrates why disease-event claims need their own evidence. ^[20]

Discussing medication and metabolic concerns in NYC

Start with the problem you want to address: medication-related weight change, rising glucose, sleep difficulties, psychiatric symptoms or several of these together. The treatment plan should identify relevant measurements, the clinicians involved and the point at which progress will be reviewed.

A ketogenic intervention requires particular attention when diabetes medication, a history of severe mood instability or nutritional concerns are present. In an Edinburgh feasibility study, one participant taking an SGLT2 inhibitor experienced euglycemic ketoacidosis. Medication and dietary changes need coordinated clinical planning. ^[16]

Adults who live or work in Manhattan can bring these concerns to an NYC psychiatric evaluation or medication review. Integrative Psych’s team at 80 Eighth Avenue in Chelsea can discuss clinician fit. Explain whether you want help with psychiatric symptoms, medication-related weight change or coordination with medical care, and confirm what assessment and support are available before booking.

Using metabolic psychiatry research in your treatment plan

Metabolic psychiatry provides a reason to assess psychiatric symptoms and physical health together. For selected patients, a structured nutrition intervention may become part of that plan. The current evidence supports careful goals, medication review and follow-up, while larger and longer trials clarify who benefits from ketogenic treatment and whether those benefits persist.

Frequently asked questions

What is metabolic psychiatry?

Metabolic psychiatry studies relationships among metabolism, psychiatric illness and treatments directed at metabolic dysfunction. It includes medication effects, insulin resistance, nutrition, sleep and brain energy research.

Is metabolic psychiatry the same as a ketogenic diet?

The field includes several approaches. Ketogenic dietary therapy aims to produce nutritional ketosis; other research examines exercise, diet quality and medications that affect metabolic function.

How does nutritional psychiatry relate to metabolic psychiatry?

Nutritional psychiatry studies diet quality, nutrients and mental health. Metabolic psychiatry includes this research alongside medication effects, insulin resistance and other metabolic approaches. A nutritional intervention can be studied without aiming to produce ketosis.

How strong is the psychiatric evidence for ketogenic treatment?

The evidence remains early. A small randomized depression trial found a modest short-term advantage, while bipolar and psychosis findings have important design and follow-up limitations. Lasting remission and relapse prevention remain uncertain.

Can psychiatric medication affect metabolic health?

Several psychiatric medications can affect weight, glucose or lipids. Risk differs by medication and individual. A medication review should consider metabolic changes alongside symptom benefit and overall functioning.

How can I discuss metabolic concerns with an NYC psychiatrist?

Tell the NYC team whether you want a psychiatric evaluation or medication review, and describe concerns about weight, glucose or sleep. Confirm clinician fit, availability and the assessment or coordination available before scheduling.